Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
Condition: Sintilimab and Anlotinib in Combination With Chemotherapy Intervention: Drug: Sintilimab and anlotinib in combination with chemotherapy Sponsor: Tang-Du Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research